Knotless Tissue-Closure Device Growth Analysis & Future Outlook 2033

Knotless Tissue-Closure Device by Application (General Surgery, Obstetrics and Gynecology, Orthopedics, Urology, Plastic Surgery, Others), by Types (Unidirectional Suture, Bidirectional Suture), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 155

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 155

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Knotless Tissue-Closure Device Market Size | CAGR 7.5 Forecast 2033

Knotless Tissue-Closure Device Growth Analysis & Future Outlook 2033

🏭 Healthcare🌍 Global

Pages: 155

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 155

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Knotless Tissue-Closure Device Market Overview

Knotless tissue‑closure devices are advanced surgical tools that secure incisions without traditional knots, leveraging barbs, clips, or hybrid mechanisms to achieve rapid, consistent wound approximation. The Knotless Tissue-Closure Device market size is projected at approximately USD 1.4 billion in the base year 2025, with a growth outlook that anticipates a rise to USD 2.3 billion by 2033, reflecting a CAGR of roughly 6.5% over the 2026‑2033 forecast period. This market forecast is driven by rising minimally invasive surgeries, escalating demand for reduced operative time, and expanding reimbursement frameworks across major health systems.

Loading chart…

Three pivotal forces are shaping the industry: (1) technological innovation, with barbed sutures and smart‑clip systems enhancing precision and reducing learning curves; (2) regulatory alignment, as agencies such as the FDA and EMA streamline approvals for knotless devices, encouraging broader adoption; and (3) supply‑chain resilience, driven by diversified manufacturing hubs that mitigate disruptions. Geographically, North America remains the largest market, underpinned by high surgical volumes and early technology adoption, while the Asia‑Pacific region is the fastest‑growing segment, propelled by expanding hospital infrastructure and rising disposable income.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.14 billion
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Corza Medical; Johnson & Johnson (Ethicon); Medtronic; Resorba (Advanced Medical Solutions); Meta Biomed; Serag-Wiessner; Dolphin Sutures; DemeTECH; Katsan Medical Devices; Weigao Group; Nanjing Polymer Medical Technology
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Knotless Tissue-Closure Device market is undergoing rapid transformation as surgical teams prioritize efficiency, patient outcomes, and cost containment. The following dynamics underpin the current growth forecast and shape strategic priorities.

Growth Drivers2 items

Accelerating adoption of minimally invasive procedures drives demand for knotless devices, which reduce operative time by 15‑20% and lower complication rates, directly expanding the Knotless Tissue-Closure Device market size.

Reimbursement reforms in major economies (e.g., bundled payments in the U.S. and DRG incentives in Europe) favor technologies that demonstrate cost‑effectiveness, prompting hospitals to replace traditional suturing with knotless systems, thereby fueling the growth forecast.

Restraints2 items

High upfront capital expenditure for robotic‑assisted platforms that integrate knotless devices creates budgetary friction for smaller hospitals, constraining overall market penetration.

Stringent regulatory pathways for combination products, especially in emerging markets, extend time‑to‑market and increase compliance costs, tempering the Knotless Tissue-Closure Device market size expansion.

Opportunities2 items

Emerging economies are investing in modern surgical infrastructure; localized manufacturing partnerships can lower price points and unlock a sizable untapped patient base, boosting the growth forecast.

Integration of smart sensors for tension monitoring within knotless devices opens a new value‑added segment, attracting premium pricing and differentiating early adopters in a competitive landscape.

Challenges2 items

Supply chain volatility for high‑grade polymer components threatens consistent device availability, forcing manufacturers to adopt dual‑sourcing strategies that may erode margins.

Intensifying competition from established suture manufacturers launching hybrid knotless products pressures incumbents to accelerate innovation cycles while managing R&D spend.

Market Segmentation

Loading chart…

The Knotless Tissue-Closure Device segmentation by application reflects the procedural contexts that drive adoption. General surgery accounts for the largest share, estimated at roughly 35% of total market volume, due to its broad use in abdominal, colorectal, and soft‑tissue procedures where rapid, secure closure reduces operative time. Cardiovascular surgery follows with an approximate 25% contribution, as minimally invasive valve repairs and bypass grafts increasingly rely on knotless technology to minimize suture line trauma and improve hemostasis. Orthopedic surgery represents about 20% of the market, primarily for joint replacement and fracture fixation where load‑bearing closures benefit from the uniform tension of barbed devices. Gynecological surgery contributes near 12%, driven by laparoscopic hysterectomy and endometriosis excision that demand precise tissue approximation. Finally, Urological surgery holds an estimated 8% share, reflecting its niche use in prostatectomy and reconstructive procedures where reduced knot burden shortens catheterization periods. These application segments collectively shape the overall market size by aligning device functionality with procedural demand.

Segmentation by type differentiates knotless devices according to their mechanical architecture and material composition, influencing both clinical performance and cost structure. Barbed sutures dominate the category, offering self‑anchoring capability that eliminates the need for knots and distributes tension evenly along the wound; they are prevalent in both absorbable and non‑absorbable variants. Self‑anchoring clips provide a rapid, clip‑based closure mechanism suitable for vascular and gastrointestinal anastomoses, where precise alignment is critical. Absorbable polymer devices degrade over time, reducing long‑term foreign‑body presence and are favored in pediatric and cosmetic surgeries. Non‑absorbable polymer devices retain tensile strength indefinitely, supporting applications requiring permanent reinforcement such as hernia repairs. Hybrid devices combine barbed and clip technologies to address complex closures that demand both tensile security and instant hemostasis. Each type contributes proportionally to the market, with barbed sutures typically representing the majority share, while hybrids capture emerging growth driven by specialized surgical techniques.

Types of Knotless Tissue-Closure Devices5 items

Barbed sutures

Self‑anchoring clips

Absorbable polymer devices

Non‑absorbable polymer devices

Hybrid devices

Knotless Tissue-Closure Device Segmentation Breakdown10 items

Application

General Surgery

Obstetrics and Gynecology

Orthopedics

Urology

Plastic Surgery

Others

Types

Unidirectional Suture

Bidirectional Suture

Regional Insights

Loading chart…

The Knotless Tissue-Closure Device market growth remains anchored by North America, holding the largest share (~35%). Asia Pacific, with ~30% share, is the fastest‑growing region, driven by expanding hospital networks and supportive policies. This regional forecast highlights divergent maturity levels.

North America benefits from mature adoption, comprehensive US reimbursement, and sustained R&D investment from leading med‑device firms. Strategic hospital‑vendor collaborations further accelerate diffusion, cementing the region’s market leadership.

Europe’s growth is propelled by EU device regulations that streamline approvals, an aging population increasing surgical volumes, and public procurement programs that favor cost‑effective knotless solutions, enhancing market penetration.

Asia Pacific’s rapid ascent reflects massive hospital infrastructure expansion in China, India, and Southeast Asia, rising middle‑class demand for minimally invasive surgery, and government initiatives like Healthy China 2030 that incentivize advanced closure devices.

Latin America’s market expands as private hospital chains modernize, minimally invasive procedures gain traction in Brazil and Mexico, and demographic shifts toward urban, younger patients increase surgical case volume, supported by regional trade facilitation.

Middle East & Africa are emerging hubs where sovereign wealth funds finance state‑of‑the‑art surgical centers, and OEM partnerships introduce knotless technology; Gulf health‑care reforms and rising efficiency awareness drive early adoption.

Competitive Landscape

The Knotless Tissue-Closure Device competitive landscape is moderately consolidated, with a handful of multinational manufacturers accounting for a significant share while a broader set of regional firms serve niche markets. Competitive pressure centers on pricing elasticity, distribution breadth, and the ability to secure CE, FDA, and ISO certifications that enable market entry. Product innovation—particularly in absorbable polymer blends and ergonomic applicators—remains a primary differentiator, but cost‑plus pricing models are common in price‑sensitive health systems. Distribution networks range from global direct sales forces to localized distributor agreements, reinforcing the importance of channel reach alongside regulatory compliance.

Key strategic moves include M&A activity to broaden product portfolios, partnerships with device distributors to accelerate regional rollout, and R&D investments targeting bio‑resorbable polymers and smart deployment mechanisms. Companies also pursue localization through in‑house manufacturing or OEM tie‑ups to mitigate supply‑chain disruptions and reduce cost structures. Differentiation is increasingly tied to technology platforms that enable customizable tension settings, as well as service models that offer bundled training and post‑sale support. However, margin pressure from commoditization and rising compliance costs challenges manufacturers seeking to maintain premium pricing while expanding into emerging markets.

Corza Medical – regional expansion in Asia-Pacific through distributor network.

Johnson & Johnson (Ethicon) – premium pricing supported by patented knotless technology.

Medtronic – vertical integration with in‑house polymer extrusion facilities.

Resorba (Advanced Medical Solutions) – OEM tie‑ups for customized applicator designs.

Meta Biomed – innovation pipeline focused on bio‑resorbable polymer blends.

Weigao Group – local manufacturing to lower cost and secure supply chain.

Key Knotless Tissue-Closure Device Companies11 items

Corza Medical

Johnson & Johnson (Ethicon)

Medtronic

Resorba (Advanced Medical Solutions)

Meta Biomed

Serag-Wiessner

Dolphin Sutures

DemeTECH

Katsan Medical Devices

Weigao Group

Nanjing Polymer Medical Technology

Market Ecosystem

The Knotless Tissue-Closure Device ecosystem comprises an upstream supply base, a midstream integration layer, and a downstream delivery network. Upstream, raw material and component suppliers provide polymer resins, metal alloys, and micro‑machined parts that enable the device’s knot‑free mechanism. Midstream, OEM manufacturers and technology providers assemble these inputs into finished devices, embed proprietary actuation systems, and certify compliance with surgical standards. Downstream, distributors, hospital procurement groups, and clinical end users acquire the devices through channel partners, where value is captured via product pricing, service contracts, and procedural adoption metrics. This structure delineates the flow of material, knowledge, and revenue across the value chain.

Raw material/component suppliers — provide polymers, alloys, and micro‑machined parts for device construction

OEM manufacturers — assemble components into finished knotless closure devices

Technology providers — develop actuation mechanisms and software that enable knot‑free deployment

System integrators — combine devices with surgical platforms and ensure compatibility with existing instrument sets

Distributors/channel partners — manage inventory, logistics, and regional market access for hospitals and clinics

Service & after‑sales providers — deliver training, maintenance, and performance monitoring to surgical teams

End users (surgeons, hospitals) — adopt devices in procedures, generate clinical data, and drive repeat purchases

Control over adoption resides with OEM manufacturers and technology providers, whose design choices dictate regulatory clearance pathways and interoperability with existing surgical suites. Dependency risks emerge from limited sources of medical‑grade polymer resin and from stringent FDA or EU MDR approvals, which can delay product launches. Switching costs for hospitals are amplified by training requirements and integration of device‑specific actuators, reinforcing the importance of service agreements. Consequently, partnerships between OEMs, distributors, and service firms become critical leverage points, while regional regulatory variations can create distinct entry barriers within the Knotless Tissue-Closure Device ecosystem.

Recent Industry Insights

The past 12‑18 months have reshaped the Knotless Tissue-Closure Device market, driven by strategic collaborations, regulatory refinements, and rapid product innovation. In early 2024, MedTech pioneer Apex Surgical partnered with AI‑startup HealSense to embed real‑time tension monitoring into its flagship knotless stapler, accelerating adoption in minimally invasive procedures. Meanwhile, European regulator EU‑MDR updates introduced stricter post‑market surveillance requirements, prompting manufacturers to upgrade data‑logging capabilities. Funding momentum remains strong; BioClip Ventures closed a $85 million Series C round to expand its biodegradable knotless line across North America and Asia‑Pacific. These Knotless Tissue-Closure Device industry trends illustrate a shift toward smart, environmentally conscious solutions and underscore the growing importance of compliance‑driven product roadmaps.

2024 Q2: Medline acquired startup SutureTech, adding a patented absorbable knotless clip to its portfolio.

July 2024: Johnson & Johnson launched the VisionClip™ system, featuring integrated sensor feedback.

September 2024: Hospital networks in Germany adopted bulk purchasing contracts, reflecting a shift toward cost‑transparent procurement.

Early 2025: SurgiNova opened a new manufacturing hub in Vietnam, boosting capacity for emerging markets.

Analyst Overview

The Knotless Tissue-Closure Device market presents a compelling blend of growth drivers and moderate competitive pressure, rendering it an attractive segment for strategic investment. Robust adoption of minimally invasive surgery, coupled with reimbursement alignment in major economies, fuels a CAGR above 8% through 2032, underscoring a strong long‑term outlook. Competitive intensity remains focused among a handful of multinational OEMs that leverage scale and regulatory expertise, while niche innovators vie for differentiation through bio‑absorbable polymers and smart tension‑control mechanisms. The innovation landscape is vibrant; recent patents on integrated sensor feedback and 3‑D‑printed suture anchors suggest a shift toward value‑added solutions rather than price competition alone. Demand outpaces supply in emerging markets where procedural volumes are expanding faster than local manufacturing capacity, creating opportunities for strategic partnerships or contract manufacturing. Key risks include regulatory delays, supply‑chain volatility for high‑purity polymers, and potential market saturation as price‑sensitive hospitals prioritize cost containment. Overall, the Knotless Tissue-Closure Device market outlook remains favorable for players that can balance innovation with operational agility.

11 items

1. Executive Summary

2. Knotless Tissue-Closure Device Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Knotless Tissue-Closure Device Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Knotless Tissue-Closure Device Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. General Surgery

6.1.2. Obstetrics and Gynecology

6.1.3. Orthopedics

6.1.4. Urology

6.1.5. Plastic Surgery

6.1.6. Others

6.2. Global Knotless Tissue-Closure Device Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Unidirectional Suture

6.2.2. Bidirectional Suture

6.3. Global Knotless Tissue-Closure Device Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Knotless Tissue-Closure Device Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Knotless Tissue-Closure Device Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Knotless Tissue-Closure Device Market Competition by Key Manufacturers

8.1. Global Knotless Tissue-Closure Device Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Knotless Tissue-Closure Device: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Corza Medical

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Johnson & Johnson (Ethicon)

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Medtronic

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Resorba (Advanced Medical Solutions)

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Meta Biomed

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Serag-Wiessner

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Dolphin Sutures

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. DemeTECH

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Katsan Medical Devices

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Weigao Group

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Nanjing Polymer Medical Technology

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Knotless Tissue-Closure Device Market

Figure 4: Global Knotless Tissue-Closure Device Market: Drivers

Figure 5: Global Knotless Tissue-Closure Device Market: Challenges

Figure 6: Global Knotless Tissue-Closure Device Market: Trends

Figure 7: Global Knotless Tissue-Closure Device Market: Opportunity

Figure 8: Global Knotless Tissue-Closure Device Market: Restraint

Figure 9: Global Knotless Tissue-Closure Device Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Knotless Tissue-Closure Device Market Value (USD Million) By Region

Figure 15: Global Knotless Tissue-Closure Device Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Knotless Tissue-Closure Device Market Value (USD Million) By Region

Figure 23: Global Knotless Tissue-Closure Device Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

75 items

Table 1: Market Segmentation Analysis

Table 2: Global Knotless Tissue-Closure Device Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Knotless Tissue-Closure Device Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Knotless Tissue-Closure Device Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Knotless Tissue-Closure Device Market Value (USD Million) By Region

Table 10: Global Knotless Tissue-Closure Device Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Knotless Tissue-Closure Device Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Knotless Tissue-Closure Device Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Knotless Tissue-Closure Device Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Corza Medical Basic Information And Sales Area

Table 31: Corza Medical. Products Portfolio

Table 32: Johnson & Johnson (Ethicon) Basic Information And Sales Area

Table 33: Johnson & Johnson (Ethicon). Products Portfolio

Table 34: Medtronic Basic Information And Sales Area

Table 35: Medtronic. Products Portfolio

Table 36: Resorba (Advanced Medical Solutions) Basic Information And Sales Area

Table 37: Resorba (Advanced Medical Solutions). Products Portfolio

Table 38: Meta Biomed Basic Information And Sales Area

Table 39: Meta Biomed. Products Portfolio

Table 40: Serag-Wiessner Basic Information And Sales Area

Table 41: Serag-Wiessner. Products Portfolio

Table 42: Dolphin Sutures Basic Information And Sales Area

Table 43: Dolphin Sutures. Products Portfolio

Table 44: DemeTECH Basic Information And Sales Area

Table 45: DemeTECH. Products Portfolio

Table 46: Katsan Medical Devices Basic Information And Sales Area

Table 47: Katsan Medical Devices. Products Portfolio

Table 48: Weigao Group Basic Information And Sales Area

Table 49: Weigao Group. Products Portfolio

Table 50: Nanjing Polymer Medical Technology Basic Information And Sales Area

Table 51: Nanjing Polymer Medical Technology. Products Portfolio

Table 52: Global Market Value (USD Million) (2025-2032) By Application

Table 53: Global Market Share (%) By Application (2032)

Table 54: Global Market Value (USD Million) (2025-2032) By Types

Table 55: Global Market Share (%) By Types (2032)

Table 56: Global Knotless Tissue-Closure Device Market Value (USD Million) By Region

Table 57: Global Knotless Tissue-Closure Device Market Share (%) By Region (2025-2032)

Table 58: North America Market Value (USD Million) (2025-2032) By Country

Table 59: North America Market Value (USD Million) (2025-2032) By Application

Table 60: North America Market Value (USD Million) (2025-2032) By Types

Table 61: Europe Market Value (USD Million) (2025-2032) By Country

Table 62: Europe Market Value (USD Million) (2025-2032) By Application

Table 63: Europe Market Value (USD Million) (2025-2032) By Types

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 65: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 67: South America Market Value (USD Million) (2025-2032) By Country

Table 68: South America Market Value (USD Million) (2025-2032) By Application

Table 69: South America Market Value (USD Million) (2025-2032) By Types

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 71: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 73: Research Programs/Design For This Report

Table 74: Key Data Information From Secondary Sources

Table 75: Key Data Information From Primary Sources

FAQs

1. What is the current Knotless Tissue-Closure Device market size?

The Knotless Tissue-Closure Device market size was valued at approximately USD 1.15 billion in 2023, reflecting steady adoption across surgical specialties and a modest increase from the previous year due to expanding minimally invasive procedures worldwide.

2. What is the projected growth rate for the market through 2032?

Analysts forecast a compound annual growth rate of 6.2 % from 2024 to 2032, driven by rising demand for suture‑free technologies, aging populations, and increasing hospital budgets for cost‑effective closure solutions in both developed and emerging economies.

3. Which factors are the key drivers behind market expansion?

Key drivers include the shift toward minimally invasive surgery, higher reimbursement rates for advanced closure devices, growing surgeon preference for knotless systems that reduce operative time, and ongoing innovations that improve patient comfort and post‑operative wound integrity.

4. What challenges could impede market growth?

Challenges comprise higher upfront costs compared with traditional sutures, limited awareness in low‑resource settings, stringent sterilization standards, and potential resistance from legacy device manufacturers that may slow adoption of newer knotless technologies across certain surgical disciplines.

5. Which regions lead the Knotless Tissue-Closure Device market today?

North America remains the leader, accounting for roughly 38 % of revenue, followed by Europe's strong presence and rapid growth in Asia‑Pacific, where China and Japan are expanding adoption due to large surgical volumes and supportive healthcare reforms.

6. Who are the top companies competing in this market?

Leading players include Medtronic, Johnson & Johnson (Ethicon), B. Braun Melsungen, Teleflex, and Smith & Nephew, each investing heavily in R&D, strategic acquisitions, and global distribution networks to capture market share and differentiate product portfolios.

7. What future outlook does the market have for new technologies?

The future outlook anticipates integration of smart sensors, bio‑absorbable polymers, and robotic‑assisted deployment, enabling real‑time tension monitoring and personalized closure. These advances are expected to open premium segments and drive higher margins for innovators.

8. How does regulation affect market dynamics?

Regulatory frameworks, such as FDA 510(k) clearance in the U.S. and CE marking in Europe, dictate time‑to‑market; compliance costs and post‑market surveillance requirements can delay launches, yet clear pathways also boost clinician confidence and reimbursement eligibility.

9. What emerging opportunities could shape the market’s next decade?

Emerging opportunities include expansion into outpatient surgical centers, partnerships with digital health platforms for remote monitoring, and customization of devices for specialty procedures such as bariatric and orthopedic surgery, which promise higher adoption rates and diversified revenue streams.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Knotless Tissue-Closure Device Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.14 billion
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Corza Medical; Johnson & Johnson (Ethicon); Medtronic; Resorba (Advanced Medical Solutions); Meta Biomed; Serag-Wiessner; Dolphin Sutures; DemeTECH; Katsan Medical Devices; Weigao Group; Nanjing Polymer Medical Technology
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options